Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DCLX069 is a selective protein arginine methyltransferase 1 (PRMT1) inhibitor with an IC50 value of 17.9 µM. DCLX069 occupies the SAM binding pocket to exert the inhibitory effect. DCLX069 effectively blocks cell proliferation in breast cancer, liver cancer, and acute myeloid leukemia cell lines.
説明 | DCLX069 is a selective protein arginine methyltransferase 1 (PRMT1) inhibitor with an IC50 value of 17.9 µM. DCLX069 occupies the SAM binding pocket to exert the inhibitory effect. DCLX069 effectively blocks cell proliferation in breast cancer, liver cancer, and acute myeloid leukemia cell lines. |
ターゲット&IC50 | PRMT1:17.9 μM (IC50) |
別名 | DCLX 069, DCLX-069 |
分子量 | 339.43 |
分子式 | C20H25N3O2 |
CAS No. | 792946-69-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/ml (176.77 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
DCLX069 792946-69-1 Chromatin/Epigenetic Histone Methyltransferase PRMT1 Inhibitor anticancer DCLX 069 DCLX-069 inhibit inhibitor